ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Selective PARP1 inhibitors, PARP1-based dual-target inhibitors, PROTAC PARP1 degraders, and prodrugs of PARP1 inhibitors for cancer therapy

Peng, Xiaopeng; Pan, Wanyi; Jiang, Feng; Chen, Weiming; Qi, Zetao; Peng, Weijie*; Chen, Jianjun*南方医科大学
Pharmacological Research2022-12DOI: 10.1016/j.phrs.2022.106529
10被引5阅读
引用收藏
分享

摘要

Poly ADP-ribose polymerase (PARP) plays a critical role in many cellular processes such as DNA damage repair, gene transcription and cell apoptosis. Therefore, targeting PARP represents a promising strategy for cancer therapy. To date, numerous small molecule PARP1 inhibitors have been identified, but many of them suffer from limited clinical efficacy and serious toxicity. Hence, PARP1 inhibitor-based combination therapies, and other PARP1 modulators (e.g. PROTAC degraders, dual acting agents) have attracted great attention with significant advancements achieved in the past few years. In this review, we overviewed the recent progress on PARP1-based drug discovery with a focus on PARP1 inhibitor-based drug combination therapy and other PARP1-targeting strategies (e.g. selective PARP1 inhibitors, PARP1-based dual-target inhibitors, PROTAC PARP1 degraders, and prodrugs of PARP1 inhibitors). In addition, we also summarized the reported co-crystal structures of PARP1 inhibitors in complex with their target proteins as well as the binding interactions. Finally, the challenges and future directions for PARP-based drug discovery in cancer therapy are also discussed in detail.

学科与关键词

关键词
CancerPARP1 inhibitorsPARP1 modulatorsCombination therapyDual targetingPROTACProdrugCrystal structures
相关
加载中…
  • Poly-ADP ribosylation in DNA damage response and cancer therapy.
    Hou, Wei-Hsien; Chen, Shih-Hsun; Yu, Xiaochun*Mutat Res, 2019, 780: 82-91.
  • Resistance to PARP Inhibitors: Lessons from Preclinical Models of BRCA-Associated Cancer
    Gogola, Ewa; Rottenberg, Sven*; Jonkers, JosANNUAL REVIEWS,4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA, 2019.被引 41
  • P63 involvement in poly(ADP-ribose) polymerase 1 signaling of topoisomerase I-dependent DNA damage in carcinoma cells
    Montariello D; Troiano A; Malanga M; Calabro V; Quesada P*Biochemical Pharmacology, 2013, 85(7): 999-1006.
查看全部 →

发表信息

论文状态
公开发表
期刊
Pharmacological Research
发表日期
2022-12
卷期
第 186 卷
页码
106529
DOI
10.1016/j.phrs.2022.106529
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Ganzhou Science and Technology Program; National Natural Science Foundation of China; Jiangxi Provincial Nat-ural Science Foundation; [2021-03]; [82260676]; [82173668]; [21961003]; [20212ACB206001]

作者

  • P

    Peng, Xiaopeng (第一作者)

    gannan med univ

  • P

    Pan, Wanyi

    gannan med univ

查看全部 7 位作者收起作者
  • J

    Jiang, Feng

    gannan med univ

  • C

    Chen, Weiming

    gannan med univ

  • Q

    Qi, Zetao

    gannan med univ

  • P

    Peng, Weijie (通讯)

    gannan med univ

  • C

    Chen, Jianjun (通讯)

    new · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417